PER-106-03已完成未知
STUDY PHASE I / II DETERMINATION OF THE DOSAGE, PHARMACOKINETICS AND SECURITY OF EPIRUBUBIN (ELLENCE TM / PHARMORRUBICINA TM FARMORRUBICINA TM) IN PEDIATRIC ONCOLOGICAL PATIENTS WITH REFRACTORY OR RECURRENT DISEASE, WITH EVALUATION OF EFFECTIVENESS IN PATIENTS WITH NEUROBLASTOMA, STS AND BONE SARCOMA, REFRACTORY.
PHARMACIA & UPJOHN INTERAMERICAN CORPORATION SUCURSAL DEL PERU,0 个研究点目标入组 0 人开始时间: 2004年1月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Be 1 year old or older, but less than 18 years old.
- •Have a histologically or ecologically documented diagnosis of solid tumor or lymphoma that progressed during one or more previous standard therapies or recurred afterwards, and for which there is no additional standard therapy.
排除标准
- •over 18 years
- •pregnant women
研究者
相似试验
招募中
1 期
Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasisiver resection for liver metastasis of colorectal cancerJPRN-UMIN000021146Oita university, faculty of medicine, department gastroenterology and pediatric surgery18
已完成
1 期
A Phase I/II, pharmacokinetics and dose-finding study of M121101 in patients with pincer nailPincer nailJPRN-jRCT2080224657Maruho co.,Ltd.68
进行中（未招募）
1 期
Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.Glaucoma or Ocular HypertensionMedDRA version: 18.1 Level: PT Classification code 10011762 Term: Cystic fibrosis System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2013-004302-26-GBSanten Oy18
进行中（未招募）
1 期
Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.Glaucoma or Ocular HypertensionMedDRA version: 18.1Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2013-004302-26-SKSanten Oy18
进行中（未招募）
1 期
Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.Glaucoma or Ocular HypertensionMedDRA version: 18.1Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2013-004302-26-HUSanten Oy18